KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Equity (2016 - 2025)

Sarepta Therapeutics has reported Return on Equity over the past 15 years, most recently at 0.06% for Q4 2025.

  • Quarterly results put Return on Equity at 0.06% for Q4 2025, down 23.0% from a year ago — trailing twelve months through Dec 2025 was 0.06% (down 23.0% YoY), and the annual figure for FY2025 was 0.06%, down 26.0%.
  • Return on Equity for Q4 2025 was 0.06% at Sarepta Therapeutics, up from 0.2% in the prior quarter.
  • Over the last five years, Return on Equity for SRPT hit a ceiling of 0.35% in Q3 2024 and a floor of 1.57% in Q1 2023.
  • Median Return on Equity over the past 5 years was 0.19% (2025), compared with a mean of 0.4%.
  • Biggest five-year swings in Return on Equity: plummeted -159bps in 2023 and later skyrocketed 190bps in 2024.
  • Sarepta Therapeutics' Return on Equity stood at 0.07% in 2021, then crashed by -1532bps to 1.11% in 2022, then surged by 72bps to 0.31% in 2023, then soared by 155bps to 0.17% in 2024, then plummeted by -137bps to 0.06% in 2025.
  • The last three reported values for Return on Equity were 0.06% (Q4 2025), 0.2% (Q3 2025), and 0.05% (Q2 2025) per Business Quant data.